by Bruce Sylvester – Metformin therapy at 500 twice daily (BID) is not protective against heart failure in non-diabetic patients following a heart attack, researchers reported on March… read more.
by Bruce Sylvester – Using ordinary instrumentation plus a computer during nocturnal insulin delivery, scientists have found a method to predict and prevent dangerously low overnight blood sugars… read more.
World Health Matters by Gary Finnegan – Italy – Death rates from pancreatic cancer are predicted to increase in men and women in 2014 and beyond, according to… read more.
In up to 85 percent of cases. “The substantial numbers of patients misdiagnosed and under diagnosed in this study is a cause for concern. It is important that… read more.
by Bruce Sylvester – For managing uncontrolled type 2 diabetes in obese patients, gastric bypass and sleeve gastrectomy are each more effective than intensive medical therapy alone.
Applying the updated 2014 blood pressure (BP) guideline to the U.S. population suggests that nearly 6 million adults are no longer classified as needing hypertension medication, and that… read more.
Although some research has suggested that metformin, a medication often used in the treatment of diabetes, may have favourable effects on ventricular (heart) function, among patients without diabetes… read more.
The most frequently used mechanical circulatory assist device in the world may have untapped potential, physicians say. One of many uses for the intra-aortic balloon pump is helping… read more.
Heart problems less likely for spouses than for single, divorced and widowed people. People who are married have lower rates of several cardiovascular diseases compared with those who… read more.
Results of the study could help the 715,000 Americans who suffer from heart attacks each year. Researchers at the Intermountain Medical Center Heart Institute in Salt Lake City… read more.
Obese people who have stomach surgery to help them lose weight will halve their risk of heart attack according to new research from a team of doctors at… read more.
Use of the drug aleglitazar, which has shown the ability to lower glucose levels and have favorable effects on cholesterol, did not reduce the risk of cardiovascular death,… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
